Caretaker in the Cardiovascular Intensive Care Unit (CVICU)
Validation Of Cardiac Output Using Pulse Decomposition Analysis In Post-Cardiac Surgery Patients In The ICU
1 other identifier
observational
50
1 country
1
Brief Summary
To monitor the cardiac post-op patient population with both the pulmonary artery catheter (PAC) and the Caretaker monitor, which will seek to validate the Caretaker monitor against continuous CO via the PAC. Up to a third of post-operative cardiac surgery patients develop cardiac arrhythmias such as atrial flutter and atrial fibrillation. Secondary analysis will be performed on the collected data to assess the Caretaker monitor's agreement with the PAC during periods of arrhythmia. Successful completion this study will provide clinical validation of the Caretaker monitor in one of the most hemodynamically challenging patient populations (post-cardiac surgery patients in the ICU), including during arrhythmias. The Caretaker monitor is most beneficial as it is non-invasive, is a minimal risk device, and for this protocol will not be utilized to make treatment decisions for the study subject. This device also does not project energy into the subject.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2021
CompletedFirst Submitted
Initial submission to the registry
March 9, 2023
CompletedFirst Posted
Study publicly available on registry
March 22, 2023
CompletedMarch 22, 2023
June 1, 2022
2 months
March 9, 2023
March 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Comparison of hemodynamic readings between the Caretaker and the PAC
To assess the agreement of the Caretaker monitor CO with the thermodilution method using the swan-ganz or pulmonary artery (PAC) catheter in critically ill cardiac surgery post-op ICU patients.
24 hours
Number of Periods of Carbon monoxide (CO) Instability
The incidence of CO instability after removal of PAC. Comparison of hemodynamic readings after removal of the PAC between the Caretaker and vital signs obtained as standard of care
24 hours
Time Spent in Periods of CO Instability
The time spent during periods of CO instability after removal of PAC. Comparison of hemodynamic readings after removal of the PAC between the Caretaker and vital signs obtained as standard of care.
24 hours
Study Arms (1)
Caretaker device in CVICU patient
device placed on the subject after arrival to the cardiac intensive care unit postoperatively
Interventions
placement of the device on the postoperative cardiac surgery patient that has a pulmonary artery catheter for comparison readings
Eligibility Criteria
Adult post-cardiac surgery needing cardiopulmonary bypass and use of the PAC as standard of care, (s/p CABG, valve, heart transplant, major aortic \& other vascular surgery, and a combination of CABG and valve procedures)
You may qualify if:
- Adult post-cardiac surgery needing cardiopulmonary bypass and use of the PAC as standard of care, (s/p Coronary artery bypass graft surgery (CABG), valve, heart transplant, major aortic \& other vascular surgery, and a combination of CABG and valve procedures)
- patients (age \> 18) admitted to the Intensive Care Unit (ICU)
- Pulmonary artery catheter (continuous or intermittent thermodilution cardiac output) and an arterial catheter for Blood Pressure monitoring (standard of care)
You may not qualify if:
- Patients without an appropriately positioned or functioning PA catheter admitted to the cardiac surgery ICU after surgery
- Patients on left ventricular assist device (LVAD) support
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, 27157, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Ashish Khanna, MD
Wake Forest University Health Sciences
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 9, 2023
First Posted
March 22, 2023
Study Start
November 1, 2021
Primary Completion
December 28, 2021
Study Completion
December 28, 2021
Last Updated
March 22, 2023
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share